Effects of Nephrolithiasis on Serum DNase (Deoxyribonuclease I and II) Activity and E3 SUMO-Protein Ligase NSE2 (NSMCE2) in Malaysian Individuals.
- Author:
Faridah YUSOF
1
;
Atheer Awad MEHDE
2
;
Wesen Adel MEHDI
3
;
Raha Ahmed RAUS
1
;
Hamid GHAZALI
4
;
Azlina Abd RAHMAN
5
Author Information
- Publication Type:Journal Article
- Keywords: DNase I; DNase II; E3 SUMO-protein ligase NSE2; NSMCE2; Nephrolithiasis
- MeSH: Adult; Blood Proteins; analysis; Case-Control Studies; Creatinine; blood; Deoxyribonuclease I; blood; Endodeoxyribonucleases; blood; Hemoglobins; analysis; Humans; Ligases; blood; Malaysia; Middle Aged; Nephrolithiasis; blood; enzymology; Urea; blood
- From: Biomedical and Environmental Sciences 2015;28(9):660-665
- CountryChina
- Language:English
-
Abstract:
OBJECTIVENephrolithiasis is one of the most common disorders of the urinary tract. The aim of this study was to examine a possible relationship between DNase I/II activity and E3 SUMO-protein ligase NSE2 in the sera of nephrolithiasis patients to evaluate the possibility of a new biomarker for evaluating kidney damage.
METHODSSixty nephrolithiasis patients and 50 control patients were enrolled in a case-control study. Their blood urea, creatinine, protein levels and DNase I/II activity levels were measured by spectrometry. Serum NSMCE2 levels were measured by ELISA. Blood was collected from patients of the government health clinics in Kuantan-Pahang and fulfilled the inclusion criteria.
RESULTSThe result indicated that mean levels of sera NSMCE2 have a significantly increase (P<0.01) in patients compared to control group. Compared with control subjects, activities and specific activities of serum DNase I and II were significantly elevated in nephrolithiasis patients (P$lt;0.01).
CONCLUSIONThis study suggests that an increase in serum concentrations of DNase I/II and E3 SUMO-protein ligase NSE2 level can be used as indicators for the diagnosis of kidney injury in patients with nephrolithiasis.